TGF-β signaling is required for the function of insulin-reactive T regulatory cells
暂无分享,去创建一个
L. Wen | F. Wong | R. Sherwin | R. Flavell | Ming O. Li | W. Du | Jian Peng | Hao Qi | L. Wen
[1] A. Pugliese. The Insulin Gene In Type 1 Diabetes , 2005, IUBMB life.
[2] P. Raskin,et al. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. , 2005, Diabetes care.
[3] G. Eisenbarth,et al. The Stages of Type 1A Diabetes , 2005, Annals of the New York Academy of Sciences.
[4] G. Eisenbarth,et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice , 2005, Nature.
[5] D. Hafler,et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope , 2005, Nature.
[6] J. Krischer,et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. , 2005, Diabetes care.
[7] G. Eisenbarth,et al. The stages of type 1A diabetes: 2005 , 2005, Immunological reviews.
[8] S. Sakaguchi. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.
[9] R. Coffman,et al. T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.
[10] Bingye Han,et al. Individual Nonobese Diabetic Mice Exhibit Unique Patterns of CD8+ T Cell Reactivity to Three Islet Antigens, Including the Newly Identified Widely Expressed Dystrophia Myotonica Kinase1 , 2004, The Journal of Immunology.
[11] C. Benoist,et al. Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. , 2004, Diabetes.
[12] Jeffrey A. Bluestone,et al. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[13] Peter R. Galle,et al. Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.
[14] Christiane Pontoux,et al. Immune Regulation by Self-Reactive T Cells is Antigen Specific1 , 2004, The Journal of Immunology.
[15] Mark Peakman,et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. , 2004, The Journal of clinical investigation.
[16] B. Brors,et al. Medullary Epithelial Cells of the Human Thymus Express a Highly Diverse Selection of Tissue-specific Genes Colocalized in Chromosomal Clusters , 2004, The Journal of experimental medicine.
[17] E. Schmitt,et al. Human CD4+CD25+ regulatory T cells and infectious tolerance. , 2004, Transplantation.
[18] M. Deeg,et al. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes , 2004, Diabetologia.
[19] J. Shabanowitz,et al. Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[21] H. Weiner,et al. Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. , 2003, Journal of autoimmunity.
[22] H. Mcdevitt,et al. CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer , 2002, The Journal of experimental medicine.
[23] S. Strobel. Oral Tolerance, Systemic Immunoregulation, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.
[24] Yongzhong Wei,et al. Role of TGFβ in Development of Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice1 , 2001, The Journal of Immunology.
[25] M. Roncarolo,et al. Type 1 T regulatory cells , 2001, Immunological reviews.
[26] A. Gaur,et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. , 2001, The Journal of clinical investigation.
[27] Clemencia Pinilla,et al. Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice1 , 2001, The Journal of Immunology.
[28] V. Kuchroo,et al. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] Mahavir Singh,et al. A Conserved Mycobacterial Heat Shock Protein (hsp) 70 Sequence Prevents Adjuvant Arthritis upon Nasal Administration and Induces IL-10-Producing T Cells That Cross-React with the Mammalian Self-hsp70 Homologue1 , 2000, The Journal of Immunology.
[30] R. Flavell,et al. Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease , 2000 .
[31] F. Lepault,et al. Characterization of Peripheral Regulatory CD4+ T Cells That Prevent Diabetes Onset in Nonobese Diabetic Mice1 , 2000, The Journal of Immunology.
[32] R. Flavell,et al. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. , 2000, Immunity.
[33] P. Bingley,et al. Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetes. , 1999, Journal of autoimmunity.
[34] D. Wraith,et al. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. , 1999, International immunology.
[35] C. Janeway,et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library , 1999, Nature Medicine.
[36] H. Weiner,et al. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. , 1999, Journal of autoimmunity.
[37] S. Wahl,et al. Engagement of Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor β (TGF-β) Production by Murine CD4+ T Cells , 1998, The Journal of experimental medicine.
[38] C. Piccirillo,et al. TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice , 1998, The Journal of Immunology.
[39] J. Miyazaki,et al. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1. , 1998, The Journal of clinical investigation.
[40] C. Piccirillo,et al. TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. , 1998, Journal of immunology.
[41] P. Santamaria,et al. A Mechanism for the Major Histocompatibility Complex–linked Resistance to Autoimmunity , 1997, The Journal of experimental medicine.
[42] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[43] D. Cohen,et al. Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. , 1997, The Journal of clinical investigation.
[44] H. Weiner,et al. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. , 1997, Journal of autoimmunity.
[45] L. Wen,et al. Inhibition of Diabetes by an Insulin-Reactive CD4 T-Cell Clone in the Nonobese Diabetic Mouse , 1997, Diabetes.
[46] M. Kurrer,et al. Beta cell apoptosis in T cell-mediated autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[47] D. Wegmann,et al. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[48] V. Kouskoff,et al. Cassette vectors directing expression of T cell receptor genes in transgenic mice. , 1995, Journal of immunological methods.
[49] R. Gill,et al. Analysis of the spontaneous T cell response to insulin in NOD mice. , 1994, Journal of autoimmunity.
[50] H. Weiner,et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.
[51] Susumu Tonegawa,et al. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice , 1994, Cell.
[52] D. Wegmann,et al. Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice , 1994, European journal of immunology.
[53] C. Benoist,et al. Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.
[54] G. Proetzel,et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.
[55] G. Lathrop,et al. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility , 1991, Nature.
[56] M. Atkinson,et al. Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy , 1990, Diabetes.
[57] K. Lafferty,et al. T-Lymphocyte Clone Specific for Pancreatic Islet Antigen , 1988, Diabetes.